Measure Code | Measure Title | Performance Rate | Patient Count | Star Value | Five Star Benchmark | Collection Type |
---|---|---|---|---|---|---|
IA_EC_AHE_1 | Engagement of New Medicaid Patients and Follow-up | |||||
IA_EC_CC_1 | Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop | |||||
IA_EC_EPA_1 | Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record | |||||
IA_EC_EPA_2 | Use of telehealth services that expand practice access | |||||
MIPS_EC_093_overall | Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy Avoidance of Inappropriate Use | 93 | 46 | REG | ||
MIPS_EC_111_overall | Pneumococcal Vaccination Status for Older Adults | 99 | 426 | 5 | 99 | REG |
MIPS_EC_128_overall | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | 32 | 1133 | 2 | 100 | REG |
MIPS_EC_130_overall | Documentation of Current Medications in the Medical Record | 95 | 1706 | 4 | 100 | REG |
MIPS_EC_226_overall | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 21 | 34 | 1 | 100 | REG |
MIPS_EC_331_overall | Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) | 8 | 53 | 4 | 100 | REG |
MIPS_EC_402_overall | Tobacco Use and Help with Quitting Among Adolescents | 100 | 49 | REG | ||
PI_EC_EP_1 | e-Prescribing | 91 | 391 | 2 | 100 | REG |
PI_EC_LVOTC_1 | Support Electronic Referral Loops By Sending Health Information Exclusion | |||||
PI_EC_ONCDIR_1 | ONC Direct Review Attestation | |||||
PI_EC_ONCACB_1 | ONC-ACB Surveillance Attestation | |||||
PI_EC_PEA_1 | Provide Patients Electronic Access to Their Health Information | 89 | 434 | 4 | 100 | REG |
PI_EC_PHCDRR_5 | Clinical Data Registry Reporting | |||||
PI_EC_PHCDRR_1_EX_1 | Immunization Registry Reporting Exclusion | |||||
QCDR_EC_AAO23_overall | Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines | 78 | 672 | 4 | 88 | QCDR |
QCDR_EC_AAO24_overall | Allergic Rhinitis: Avoidance of Leukotriene Inhibitors | 100 | 356 | QCDR | ||
PI_EC_PPHI_1 | Security Risk Analysis |